FDA approves Dilons lesion-localization system

Justine Varieur Cadet | | Health Imaging | Molecular Imaging
The FDA has granted 510(k) clearance for Dilon Diagnostics’ lesion-localization system for molecular imaging biopsy guidance.

The GammaLMc, a complementary technology to the Dilon 6800 Gamma Camera, is a system to help doctors locate breast lesions and allow gamma-guided biopsies, according to the Newport News, Va.-based company.  The GammaLMc system utilizes a CorreLocator paddle and a StereoView imaging collimator system—a technique similar to that used in stereotactic x-ray localization—and the GammaLMc software calculates the location of the lesion.

Justine Varieur Cadet

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.